BioConnection congratulates BioLineRx with their FDA approval of Aphexda

We are proud that we have been able to support BioLineRx since the start of the Motixafortide BL-8040 project (and even before) and be their proud partner through all the clinical phases. It is a tremendous and well-deserved success that Aphexda is now approved to the market.

After our recent successful pre-approval FDA inspection we are ready to grow further with BioLineRx with the commercial supply. We congratulate the whole BiolineRX team with this success and hope that many patients will benefit from Aphexda! You can read the original press release here. Contacts BioConnection, Oss.

Let's connect

If you’re exploring fill & finish support for an upcoming or ongoing program, we’d love to learn more about your goals and how we can contribute to your success. Whether you’re evaluating partners for a new project or preparing for your next development milestone, our team is ready to support you with clarity, expertise, and flexibility.

Share a few details about your molecule, timelines, or specific challenges, and we’ll follow up with insights tailored to your needs. By understanding your priorities early, we can determine how our capabilities, capacity, and approach align with your plans. We’re here to help.